Literature DB >> 6350696

Levonantradol for the treatment of chemotherapy-induced nausea and vomiting.

H H Gerhartz, T Binsack, E Hiller.   

Abstract

Twenty patients with cancer previously unresponsive to antiemetic treatment of chemotherapy-induced nausea and vomiting were treated with the new tetrahydrocannabinoid Levonantradol. 15 patients experienced substantial relief and 10 of them preferred the drug for further courses. These observations suggest that Levonantradol can be beneficial to patients refractory to conventional antiemetic therapy.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6350696     DOI： 10.1007/bf01487619

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


  10 in total

1.  Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.

Authors:  T S Herman; L H Einhorn; S E Jones; C Nagy; A B Chester; J C Dean; B Furnas; S D Williams; S A Leigh; R T Dorr; T E Moon
Journal:  N Engl J Med       Date:  1979-06-07       Impact factor: 91.245

2.  Suppression of cancer chemotherapy-induced vomiting in the cat by nabilone, a synthetic cannabinoid.

Authors:  S W London; L E McCarthy; H L Borison
Journal:  Proc Soc Exp Biol Med       Date:  1979-04

3.  Incidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomised trial of antiemetics.

Authors:  C Morran; D C Smith; D A Anderson; C S McArdle
Journal:  Br Med J       Date:  1979-05-19

4.  Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.

Authors:  S E Sallan; N E Zinberg; E Frei
Journal:  N Engl J Med       Date:  1975-10-16       Impact factor: 91.245

5.  [Levonantradol in the treatment of nausea and vomiting caused by cytostatic drugs (author's transl) clinical studies].

Authors:  M Higi; N Niederle; K Bremer; G Schmitt; C G Schmidt; S Seeber
Journal:  Dtsch Med Wochenschr       Date:  1982-08-20       Impact factor: 0.628

6.  Emesis as a critical problem in chemotherapy.

Authors:  J Laszlo; V S Lucas
Journal:  N Engl J Med       Date:  1981-10-15       Impact factor: 91.245

7.  [Treatment of refractory cytostatic agent-induced vomiting with the synthetic cannabinoid levonantradol].

Authors:  M E Heim; W Queisser
Journal:  Onkologie       Date:  1982-04

8.  Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis.

Authors:  L E Orr; J F McKernan; B Bloome
Journal:  Arch Intern Med       Date:  1980-11

Review 9.  The control of chemotherapy-induced emesis.

Authors:  L J Seigel; D L Longo
Journal:  Ann Intern Med       Date:  1981-09       Impact factor: 25.391

10.  Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.

Authors:  S Frytak; C G Moertel; J R O'Fallon; J Rubin; E T Creagan; M J O'Connell; A J Schutt; N W Schwartau
Journal:  Ann Intern Med       Date:  1979-12       Impact factor: 25.391
  10 in total
  1 in total

1.  [New aspects in the antiemetic therapy of cytostatic drug-induced vomiting].

Authors:  E Hiller; H Gerhartz
Journal:  Klin Wochenschr       Date:  1984-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.